Beijing Scitop Bio Tech Co Ltd (300858) — Working Capital to Net Assets Ratio
Beijing Scitop Bio Tech Co Ltd (300858) has a Working Capital to Net Assets ratio of 43.1% as of March 2026. Working capital of CN¥801.57 Million (current assets of CN¥920.62 Million minus current liabilities of CN¥119.05 Million) is measured against net assets of CN¥1.86 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 300858 net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Beijing Scitop Bio Tech Co Ltd Working Capital to Net Assets (2015–2025)
This chart shows how Beijing Scitop Bio Tech Co Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the ratio stands at 43.1%, reflecting working capital of CN¥801.57 Million against net assets of CN¥1.86 Billion CNY. Check tangible net worth ratio of Beijing Scitop Bio Tech Co Ltd to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Beijing Scitop Bio Tech Co Ltd (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Beijing Scitop Bio Tech Co Ltd from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Beijing Scitop Bio Tech Co Ltd market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 46.1% | CN¥849.74 Million | CN¥1.84 Billion | CN¥977.34 Million | CN¥127.60 Million | ▼ -1.9 pp |
| 2024 | 48.0% | CN¥858.52 Million | CN¥1.79 Billion | CN¥954.71 Million | CN¥96.19 Million | ▼ -3.8 pp |
| 2023 | 51.8% | CN¥896.91 Million | CN¥1.73 Billion | CN¥955.55 Million | CN¥58.64 Million | ▼ -21.4 pp |
| 2022 | 73.2% | CN¥1.24 Billion | CN¥1.70 Billion | CN¥1.33 Billion | CN¥85.28 Million | ▲ +1.9 pp |
| 2021 | 71.3% | CN¥690.11 Million | CN¥967.40 Million | CN¥752.59 Million | CN¥62.47 Million | ▼ -4.0 pp |
| 2020 | 75.4% | CN¥702.77 Million | CN¥932.59 Million | CN¥767.21 Million | CN¥64.43 Million | ▲ +29.0 pp |
| 2019 | 46.3% | CN¥185.27 Million | CN¥399.83 Million | CN¥249.02 Million | CN¥63.75 Million | ▲ +2.8 pp |
| 2018 | 43.5% | CN¥131.29 Million | CN¥301.83 Million | CN¥200.47 Million | CN¥69.18 Million | ▼ -25.9 pp |
| 2017 | 69.4% | CN¥195.01 Million | CN¥281.09 Million | CN¥246.99 Million | CN¥51.99 Million | ▼ -3.7 pp |
| 2016 | 73.1% | CN¥142.15 Million | CN¥194.57 Million | CN¥209.84 Million | CN¥67.70 Million | ▼ -76.8 pp |
| 2015 | 149.8% | CN¥78.92 Million | CN¥52.67 Million | CN¥148.76 Million | CN¥69.83 Million | — |